dexmedetomidine (intrathecal)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for dexmedetomidine (intrathecal), covering 2023-06-07 to 2023-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Effects of Intrathecal Dexmedetomidine as an Adjuvant to Low Dose Hyperbaric 0.5% Bupivacaine [Phase 4]